PI
RPRX icon

PGGM Investments’s Royalty Pharma RPRX Stock Holding History

PGGM Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91,855
Closed -$2.42M – 365
2024
Q2 		$2.42M Buy
91,855
+2,385
+3% +$66.1K 0.03% 248
2024
Q1 		$2.72M Hold
89,470
– – 0.04% 245
2023
Q4 		$2.51M Buy
89,470
+1,986
+2% +$54.6K 0.04% 253
2023
Q3 		$2.37M Sell
87,484
-20,003
-19% -$594K 0.04% 258
2023
Q2 		$3.3M Sell
107,487
-1,638
-2% -$55.5K 0.05% 241
2023
Q1 		$3.93M Hold
109,125
– – 0.07% 231
2022
Q4 		$4.31M Buy
109,125
+3,173
+3% +$132K 0.08% 206
2022
Q3 		$4.26M Buy
+105,952
New +$4.53M 0.07% 221
2021
Q3 		– Sell
-4,135
Closed -$169K – 428
2021
Q2 		$169K Buy
+4,135
New +$176K ﹤0.01% 433

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return